KEYNOTE-024 Update: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced NSCLC with PD-L1 Tumor Proportion Score >= 50%

Brahmer, J; Rodriguez-Abreu, D; Robinson, A; Hui, R; Csoszi, T; Fulop, A; Gottfried, M; Peled, N; Tafreshi, A; Cuffe, S; O'Brien, M; Rao, S; Hotta, K; Riccio, A; Yang, J; Pietanza, MC; Reck, M

JOURNAL OF THORACIC ONCOLOGY, 2018; 13 (9): S153

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索